Found 0 matching trials
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency PHASE3 Background. Treatment with intravenous iron has been shown to improve sympt...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects PHASE1 The purpose of the study is to assess the effects of rifampin on the pharma...
Show More Learn More & Join Trial
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients PHASE4 Long-term allograft function in kidney transplant recipients (KTRs) remain ...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting. PHASE1 Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...
Show More Location
Jeonbuk National University Hospital
Learn More & Join Trial
Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia PHASE2 There are approximately 400,000 people in the UK who are living with type 1...
Show More Location
Clinical Research Unit, OCDEM, Churchill Hospital
Learn More & Join Trial
A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients PHASE4 This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Show More Learn More & Join Trial
Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy PHASE4 The DAPA-HF trial demonstrated that dapagliflozin was able to reduce the ri...
Show More Location
Cheng Hsin General Hospital
Learn More & Join Trial
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF) PHASE4 The goal of this clinical trial is to evaluate the short-term clinical outc...
Show More Location
Aswan Heart Centre
Learn More & Join Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. PHASE3 This is an international, multicentre, parallel-group, event-driven, random...
Show More Learn More & Join Trial